Sarepta Therapeutics

Patent cliffs & loss of exclusivity

Sarepta Therapeutics is a biopharmaceutical company founded by Marwan Fawaz in 1980 and headquartered in Cambridge, Massachusetts developing precision genetic medicines for the treatment of rare neuromuscular diseases.

Company

AngelList URLhttps://angel.co/sarepta-therapeutics
Legal NameSarepta Therapeutics, Inc.
Company Operating StatusActive
Contact Page URLhttps://www.sarepta.com/about-us/contact-us
Crunchbase URLhttps://www.crunchbase.com/organization/sarepta-therapeutics#section-ipo-stock-price
Facebook URLhttps://www.facebook.com/Sarepta-Therapeutics-208950446535427/
Full Address215 First Street Cambridge, MA 02142
Instagram URLhttps://www.instagram.com/sareptatherapeutics/

4 upcoming patent cliffs

DrugIngredientTypeCliff
  1. VYONDYS 53GOLODIRSENSmall mol.Jun 2028
  2. AMONDYS 45CASIMERSENSmall mol.Nov 2030
  3. EXONDYS 51ETEPLIRSENSmall mol.Mar 2034
  4. EXONDYS 51ETEPLIRSENSmall mol.Mar 2034
  5. ELEVIDYSdelandistrogene moxeparvovec-roklBiologic

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Not found